Walgreens Boots Alliance Stock News

LOS ANGELES, March 11, 2025 (GLOBE NEWSWIRE) -- Investors can contact the law firm at no cost to learn more about recovering their losses

This year's top performer among the S&P 500 has been CVS Health's stock, which had a bad 2024 and is cheap by a key valuation measure.

Troubled pharmacy chain Walgreens Boots Alliance Inc. NASDAQ: WBA has been a spectacular disappointment since completing its merging in 2014. Shares rose to a high of $97.14 following the union but had since fallen % to a low of $8.11 on November 21.

NEW YORK , March 9, 2025 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) between April 2, 2020 and January 16, 2025, both dates inclusive (the "Class Period"), of the important March 31, 2025 lead plaintiff deadline. So What: If you purchased Walgreens common stock during the Class Period...

Walgreens Boots Alliance is being acquired by Sycamore Partners, causing shares to rise 7.5% to $11.39, though long-term shareholders face a 50.2% loss since January 2024. The deal includes a $23.7 billion enterprise value, with shareholders receiving $11.45 per share plus potential additional proceeds from VillageMD, though this extra compensation is uncertain. Despite challenges and declining...

Shares in Walgreens Boots Alliance, Inc. (Nasdaq: WBA) are up a modest amount after the company announced yesterday that it has agreed to be purchased by private equity firm Sycamore Partners. As of the time of this writing, WBA shares are up under 7% to $11.33.

SAN DIEGO, March 07, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) breached their fiduciary duties in connection with the proposed sale of the Company to private equity firm Sycamore Partners.

Walgreens Boots Alliance will be taken private by Sycamore Partners in a $10 billion deal, the companies announced Thursday, marking the end of nearly a century of public trading for the US pharmacy giant.